*By Samantha Errico* Fashion brand Pirouette NYC is is providing working women appropriate, and affordable, attire to take them from the boardroom to the bar ーwith the goal of saving them both time and money. "Everyone talks about pay equity, but not about time equity ー and women don't have time to change after work to go out at night," founder Melissa Lorenzo-Hervé told Cheddar Friday. The New York-based fashion startup was founded in 2017 when an idea for a pencil skirt evolved into a collection of accessible, durable pieces that could transition seamlessly from day to evening. "When women try on the dress they really feel this transformation, they feel like there is this new level of confidence," Lorenzo-Hervé said. "They can walk into any room and own it." For full interview [click here](https://cheddar.com/videos/pirouette-nyc-creates-date-to-night-outfits-for-professional-women).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More